ArticleCancers2021

Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis.

Rouven Hoefflin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.